RUTH HUMAN: Open Payments
NPI 1891292686 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,229 in 124 payments from 32 companies in 2025. Trend: 2023 $1,751 · 2024 $1,825 · 2025 $2,229
Food & beverage: $2,229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $458 |
| ABBVIE INC. | 29 | $371 |
| PFIZER INC. | 15 | $203 |
| Novo Nordisk Inc | 9 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Axsome Therapeutics, Inc. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Medtronic, Inc. | 3 | $56 |
Products named: AIRSUPRA, UBRELVY, Ozempic, VRAYLAR, WAINUA, CAPLYTA, JARDIANCE, Auvelity.
Industry payments across IN — which companies pay providers there.
